Orphan designation: Icerguastat acetate Treatment of amyotrophic lateral sclerosis, 16/05/2022 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 13:59

Orphan designation: Icerguastat acetate Treatment of amyotrophic lateral sclerosis, 16/05/2022 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2618

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters